PHASEBIO PHARMACEUTICALS
PhaseBio is a clinical-stage biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. The company uses its proprietary recombinant biopolymers called elastin-like polypeptides (ELPs) to improve the stability, bioavailability, activity, and ease of administration of proteins and peptides, with the goal of achieving greater potency, fewer side effects, and better patient compliance. Efficient pr... oduction in E. coli ensures a low cost of goods. PhaseBio’s lead drug candidate, PB1023, is currently being evaluated in a phase 2b clinical trial for the treatment of hyperglycemia associated with type 2 diabetes, with potential for future use in the treatment of obesity. Our second drug candidate, Vasomera, is currently being evaluated in phase 1 clinical trial and has exciting potential for use in the treatment of pulmonary arterial hypertension (PAH) and heart failure. Its third program, Insumera, basal insulin based on native human insulin, will enter clinical trials in early 2013. PhaseBio is based in Malvern, Pennsylvania.
PHASEBIO PHARMACEUTICALS
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
2002-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.phasebio.com
Total Employee:
11+
Status:
Active
Contact:
16109816520
Total Funding:
324.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
RoosterBio
RoosterBio is a biotechnology company, offers synthetic biology and regenerative medicine.
Realm Therapeutics
Realm Tx is a clinical stage biopharmaceutical company passionately committed to leveraging its proprietary immunomodulatory technology
RayzeBio
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Regor Therapeutics
Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Reneo Pharmaceuticals
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.
RegeneRx
RegeneRx is a biopharmaceutical company that designs, researches, and develops novel peptides targeted at diseases with unmet medical needs.
Neoleukin Therapeutics
Neoleukin Therapeutics is a pharmaceutical company that develops medicines to treat serious immunological disorders.
NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Nykode
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
moksha8 Pharmaceuticals
Moksha8 is a pharmaceutical company providing therapeutics for the treatment of central nervous system and mental health disorders.
Meryx
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Moleculin
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
MabVax Therapeutics
MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.
MenoGeniX
MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.
Ligand Pharmaceuticals
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease.
Lipocine
Lipocine is a specialty pharmaceutical company that develops and commercializes pharmaceutical products.
Applied BioMath
Applied BioMath helps biotechnology and pharmaceutical companies accelerate and de-risk drug research and development.
AVM Biotechnology
AVM Biotechnology is a clinical stage company.
AxoGen
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
Avanir Pharmaceuticals
Avanir Pharmaceuticals is a biopharmaceutical company focused on providing medicines to patients with central nervous system disorders.
Antabio
Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Aptiv Solutions
Aptiv is a biopharmaceutical and medical device company that offers a variety of clinical trial services.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Afferent Pharmaceuticals
Afferent Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines to treat chronic pain.
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Encore Dermatology
Encore is a dermatology company that provides prescription therapies and medical devices to dermatologists.
Embera NeuroTherapeutics
Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions.
Kiora Pharmaceuticals
Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.
Boaoxin
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.
Biothera
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
Beihai Biotech
Beihai Bio is a biotechnology and pharmaceutical company that researches, develops, and produces safe anti-cancer drugs.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Terns Pharmaceuticals
Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.
Jennerex Biotherapeutics
Jennerex is a clinical-stage biopharmaceutical company developing targeted oncolytic products for the treatment of cancer.
Osteal Therapeutics
Osteal Therapeutics is a clinical stage specialty pharmaceutical company developing novel treatments for orthopedic infections.
QuVa Pharma
QuVa Pharma is a quality-compliant manufacturer of compounded and ready-to-administer sterile injectable products.
Knight Therapeutics
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing
Synaptogenix
Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.
Symbiomix Therapeutics
Symbiomix Therapeutics is a privately-held biopharmaceutical company that offers anti-infective drug and single dose treatment.
SOFIE
SOFIE is a molecular imaging company focused on empowering people with new PET technologies.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Senolytic Therapeutics
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.
Selecta Biosciences
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Dice Therapeutics
Dice Therapeutics develops a transformative platform designed for the discovery of novel small molecules.
Decipher Biosciences
Decipher Biosciences offers genomic tests for urological cancers.
Humacyte
Humacyte develops products for vascular diseases and replacement of anatomical conduits.
Innate Pharma
Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.
Inventiva Pharma
Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Immuneering
Immuneering is a bioinformatics company that develops new medicines unlikely to be found by traditional drug discovery methods.
Grace Therapeutics
Grace Therapeutics is a pharmaceutical company that focuses on drug delivery treatment for rare and orphan diseases.
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Opsens
Opsens’ high accuracy fiber optic temperature sensor and ultra miniature pressure sensor offer many distinctive advantages for the Life
OSE Immunotherapeutics
OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing.
Oxford Cannabinoid Technologies
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
Ocuphire Pharma
Ocuphire Pharma, a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.
OncoImmune
OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.
Cirius Therapeutics
Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
Ziphius
Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
Zentalis Pharmaceuticals
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Clinipace
Clinipace is a clinical research firm that offers integrated clinical research services for biopharmaceutical and medical firms.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
CinCor Pharma
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Cure Pharmaceutical
Cure Pharmaceutical is a specialty pharmaceutical and bioscience company, develops drug formulation and delivery technologies.
CardioFocus
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Cassava Sciences
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Cell Care Therapeutics
Developing first-in-class stem cell derived biopharmaceuticals to treat inflammatory and degenerative ophthalmic diseases.
Cytrellis Biosystems
Cytrellis is a medical technology company that develops aesthetic devices.
Chord Therapeutics
Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.
Constellation Pharmaceuticals
Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
Cotinga Pharmaceuticals
Cotinga Pharmaceuticals discovers and develops drug therapies for diseases.
Catalyst Biosciences
Catalyst Biosciences is a drug r and d company creating catalytic biopharmaceutical products based on engineered human proteases.
Portage Biotech
Portage Biotech is a pharmaceutical company that identifies and develops best-in-class or first-in-class early-to-mid stage products.
POLYNEURON
Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.
PhotoPharmics
PhotoPharmics is a clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
PeriphaGen
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products.
Proteon Therapeutics
Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
SFJ Pharmaceuticals
SFJ Pharmaceuticals investment in Post-IPO Equity - PhaseBio Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series D - PhaseBio Pharmaceuticals
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series D - PhaseBio Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series D - PhaseBio Pharmaceuticals
Syno Capital
Syno Capital investment in Series D - PhaseBio Pharmaceuticals
Fletcher Spaght, Inc.
Fletcher Spaght, Inc. investment in Series D - PhaseBio Pharmaceuticals
Mountain Group Capital
Mountain Group Capital investment in Series D - PhaseBio Pharmaceuticals
AstraZeneca
AstraZeneca investment in Series D - PhaseBio Pharmaceuticals
Hatteras Venture Partners
Hatteras Venture Partners investment in Series D - PhaseBio Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series D - PhaseBio Pharmaceuticals
Official Site Inspections
http://www.phasebio.com Semrush global rank: 1.92 M Semrush visits lastest month: 11.36 K
Unable to get host informations!!!
More informations about "PhaseBio Pharmaceuticals"
PhaseBio Pharmaceuticals - Crunchbase Company Profile & Funding
PhaseBio is a clinical-stage biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular …See details»
PhaseBio Pharmaceuticals, Inc. - AnnualReports.com
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and …See details»
PhaseBio Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore PhaseBio Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 14 clinical trials, 38 news, and 15 literature, Disease Domain:Endocrinology and …See details»
PhaseBio Pharmaceuticals - Contacts, Employees, Board Members, …
PhaseBio Pharmaceuticals has 10 board members and advisors, including Edmund P. Harrigan. Edmund P. Harrigan Board Member Dec 2018 Richard van den Broek Board Member Feb 2019See details»
PhaseBio Pharmaceuticals - Overview, News & Similar companies ...
Jan 16, 2023 PhaseBio is also leveraging its proprietary elastin-like polypeptide ("ELP") technology platform to develop therapies with the potential for less-frequent dosing and …See details»
PhaseBio Pharmaceuticals, Inc. - Dun & Bradstreet
PhaseBio Pharmaceuticals, Inc. Website. Get a D&B Hoovers Free Trial. Overview Doing Business As: PhaseBio. Company Description: Phase Bioscience is a biotechnology firm that …See details»
PhaseBio Company Profile 2024: Stock Performance & Earnings
PhaseBio Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial …See details»
PhaseBio Pharmaceuticals Inc Company Profile - Overview
PhaseBio proprietary ELP Biopolymer technology platform extends the circulating half-life of proteins and peptides and also provides a sustained-release mechanism for periods of a week …See details»
PhaseBio Pharmaceuticals Company Profile - Office Locations
Jan 4, 2023 PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic …See details»
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year …
Mar 24, 2022 PhaseBio Pharmaceuticals, Inc. Balance Sheets (in thousands) December 31, 2021 December 31, 2020 Assets: Cash and cash equivalents $ 41,800 $ 28,122 Other …See details»
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial …
Mar 15, 2021 PhaseBio Pharmaceuticals, Inc. Condensed Balance Sheets (in thousands) December 31, 2020 December 31, 2019 Assets: Cash and cash equivalents $ 28,122See details»
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial …
May 16, 2022 Investor Contact: John Sharp PhaseBio Pharmaceuticals, Inc. Chief Financial Officer (610) 981-6506 [email protected] Media Contact: Will Zasadny Canale …See details»
PhaseBio Pharmaceuticals, Inc. (PhaseBio Pharmaceuticals, Inc.)
了解PhaseBio Pharmaceuticals, Inc. (PhaseBio Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的13项临床试验, 46篇新闻和1篇文献，疾病领域:内分泌与代谢疾病，技 …See details»
Document - SEC.gov
•Achieved Enrollment Milestones Supporting Interim Analysis of REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor: In August 2021, …See details»
PhaseBio Files for Bankruptcy Following Blackstone-Backed …
Oct 24, 2022 PhaseBio Pharmaceuticals Inc., a publicly traded heart-disease drug developer, filed for chapter 11 bankruptcy protection weeks after being sued for breach of contract by a …See details»
PhaseBio – A Drug Development Financing (Almost) Tested in …
Jan 9, 2023 To support the recharacterization claim, PhaseBio pointed to the pure risk-capital nature of the investment, highlighting the five-times return SFJ could receive and the fact that …See details»
PhaseBio Launches Clinical Trial to Evaluate PB1046 as a ... - Nasdaq
May 27, 2020 PhaseBio receives clearance of IND application from U.S. FDA under Coronavirus Treatment Acceleration Program. MALVERN, Pa.& SAN DIEGO---- PhaseBio …See details»
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial
Mar 15, 2021 PhaseBio Pharmaceuticals, Inc. Statements of Operations (in thousands, except share and per share amounts) Quarter Ended December 31,. Year Ended December 31,. …See details»
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full
Mar 24, 2022 PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel …See details»
PhaseBio Pharmaceuticals, Inc. (PHASQ) Latest Stock News
Sep 30, 2024 PhaseBio reports full results of phase 2b trial of bentracimab to reverse ticagrelor's antiplatelet activity SA News Mon, Apr. 04, 2022. PhaseBio Pharmaceuticals GAAP EPS of …See details»